Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

Study Description

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Condition or disease	Intervention/treatment
Prostate Cancer	Behavioral: questionnaires of quality of life

Study Design

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Observational
Estimated Enrollment :	225 participants
Observational Model:	Cohort
Time Perspective:	Prospective
Official Title:	Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men
Actual Study Start Date :	July 25, 2010
Estimated Primary Completion Date :	December 31, 2018
Estimated Study Completion Date :	December 31, 2018

Groups and Cohorts

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort	Intervention/treatment
questionnaires; Black men with prostate cancer	Behavioral: questionnaires of quality of life; Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression coping methods, resilience spirituality, religiosity, and quality of life measures and will take approximately one 30 to 45 minutes to complete by patient.

Outcome Measures

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ]

Secondary Outcome Measures :

1. To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ]

Eligibility Criteria

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	Male
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Black men with prostate cancer

Criteria

Inclusion Criteria:

• 18 years of age or older
• Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
• Diagnosis of prostate cancer
• Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
• Ability to comprehend and complete questionnaires in English

Exclusion Criteria:

• Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
• Other non-Black or non-African-American ethnic groups

Contacts and Locations

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

United States, New York
Downstate Medical Center
Brooklyn, New York, United States, 11203
Kings County Hopsital Center
Brooklyn, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065

Sponsors and Collaborators

Memorial Sloan Kettering Cancer Center

University School of Medicine(VA-NYU)

State University of New York - Downstate Medical Center

Kings County Hospital Center

Investigators

Principal Investigator:	Christian Nelson, PhD	Memorial Sloan Kettering Cancer Center

More Information

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Additional Information:

Memorial Sloan Kettering Web Site 

Responsible Party:	Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:	NCT00581672 History of Changes
Obsolete Identifiers:	NCT00602654
Other Study ID Numbers:	07-125
First Posted:	December 28, 2007
Last Update Posted:	January 17, 2018
Last Verified:	January 2018

Keywords provided by Memorial Sloan Kettering Cancer Center:

Anxiety; Black men; Prostate Cancer; 07-125

Additional relevant MeSH terms:

Prostatic Neoplasms; Anxiety Disorders; Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site	Neoplasms; Genital Diseases, Male; Prostatic Diseases; Mental Disorders